PUBLISHER: IMARC | PRODUCT CODE: 1467881
PUBLISHER: IMARC | PRODUCT CODE: 1467881
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type, Application, End User, and Region 2024-2032
The global autologous stem cell and non-stem cell based therapies market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.6 Billion by 2032, exhibiting a growth rate (CAGR) of 11.87% during 2024-2032. The increasing prevalence of life-threatening diseases, the expanding geriatric population, and ongoing advancements in stem cell technologies represent some of the key factors driving the market.
Autologous stem cell therapy is a medical procedure in which a patient's stem cells are used to repair damaged tissues and organs or treat various diseases. The procedure involves harvesting stem cells from a patient's body, usually from bone marrow or adipose tissue, and then processing and injecting them back into the body. Non-stem cell-based therapies, on the other hand, involve using cells that are not stem cells, such as immune cells, fibroblasts, and muscle cells, to repair or regenerate damaged tissues or organs. Autologous stem cell therapy is used to treat cardiovascular diseases, neurodegenerative diseases, and autoimmune disorders, while non-stem cell-based therapies are employed in treating chronic wounds, heart disease, and Parkinson's disease.
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends:
The growth of the global autologous stem cell and non-stem cell based therapies market is primarily driven by the increasing prevalence of cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases due to smoking, poor diet, and sedentary lifestyles of consumers. Besides this, the rising geriatric population and the growing demand for autologous stem and non-stem cell based therapies are creating a positive outlook for the market. Moreover, the ongoing development of innovative autologous stem cell therapies for regenerative medicine and the widespread demand for personalized therapies are presenting remunerative growth opportunities for the market. In addition to this, the surging popularity of minimally invasive treatments, the expanding acceptance of stem cell therapies, and the implementation of favorable government initiatives, such as financial and regulatory support for stem cell research, are aiding in market expansion. Furthermore, continuous advancements in stem cell technologies have enabled researchers to better control the differentiation of stem cells and develop improved and effective treatments, which, in turn, is acting as a significant growth-inducing factor. Besides this, the bolstering growth of the healthcare sector, extensive research and development (R&D) activities, the escalating health consciousness among consumers, and favorable reimbursement policies are contributing to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global autologous stem cell and non-stem cell based therapies market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, application, and end user.
Type Insights:
Autologous Stem Cells
Autologous Non-Stem Cells
The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the type. This includes autologous stem cells and autologous non-stem cells. According to the report, autologous stem cells represented the largest segment.
Application Insights:
Cancer
Neurodegenerative Disorders
Cardiovascular Disease
Orthopedic Diseases
Others
A detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the application has also been provided in the report. This includes cancer, neurodegenerative disorders, cardiovascular disease, orthopedic diseases, and others. According to the report, cancer accounted for the largest market share.
End User Insights:
Hospitals
Ambulatory Surgical Centers
Research Facilities
The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the end user. This includes hospitals, ambulatory surgical centers, and research facilities. According to the report, hospitals represented the largest segment.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for autologous stem cell and non-stem cell based therapies. Some of the factors driving the North America autologous stem cell and non-stem cell based therapies market included the expanding prevalence of chronic diseases, the rising demand for personalized medicines, and continuous advancements in stem cell technologies.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global autologous stem cell and non-stem cell based therapies market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BrainStorm Cell Limited, Cytori Therapeutics Inc., Holostem Terapie Avanzate S.r.l., Lisata Therapeutics, U.S. Stem Cell Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global autologous stem cell and non-stem cell based therapies market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global autologous stem cell and non-stem cell based therapies market?
- What is the impact of each driver, restraint, and opportunity on the global autologous stem cell and non-stem cell based therapies market?
- What are the key regional markets?
- Which countries represent the most attractive autologous stem cell and non-stem cell based therapies market?
- What is the breakup of the market based on the type?
- Which is the most attractive type in the autologous stem cell and non-stem cell based therapies market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the autologous stem cell and non-stem cell based therapies market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the autologous stem cell and non-stem cell based therapies market?
- What is the competitive structure of the global autologous stem cell and non-stem cell based therapies market?
- Who are the key players/companies in the global autologous stem cell and non-stem cell based therapies market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Autologous Stem Cells
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Autologous Non-Stem Cells
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Neurodegenerative Disorders
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cardiovascular Disease
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Orthopedic Diseases
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Research Facilities
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 BrainStorm Cell Limited
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Cytori Therapeutics Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Holostem Terapie Avanzate S.r.l.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Lisata Therapeutics
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 U.S. Stem Cell Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.1 BrainStorm Cell Limited
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Major Drivers and Challenges
- Figure 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Type (in %), 2023
- Figure 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Application (in %), 2023
- Figure 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by End User (in %), 2023
- Figure 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Region (in %), 2023
- Figure 8: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Country (in %), 2023
- Figure 76: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Drivers, Restraints, and Opportunities
- Figure 78: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Value Chain Analysis
- Figure 79: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Industry Highlights, 2023 & 2032
- Table 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Competitive Structure
- Table 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Players
